These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15691064)

  • 1. Immunoprotective potential of polysaccharide-tetanus toxoid conjugate in Klebsiella pneumoniae induced lobar pneumonia in rats.
    Chhibber S; Rani M; Vanashree Y
    Indian J Exp Biol; 2005 Jan; 43(1):40-5. PubMed ID: 15691064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective role of liposome incorporated lipopolysaccharide antigen of Klebsiella pneumoniae in a rat model of lobar pneumonia.
    Chhibber S; Wadhwa S; Yadav V
    Jpn J Infect Dis; 2004 Aug; 57(4):150-5. PubMed ID: 15329446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib.
    Baker CJ; Paoletti LC; Wessels MR; Guttormsen HK; Rench MA; Hickman ME; Kasper DL
    J Infect Dis; 1999 Jan; 179(1):142-50. PubMed ID: 9841833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjugation of tetanus toxoid with Salmonella typhimurium PTCC 1735 O-specific polysaccharide and its effects on production of opsonizing antibodies in a mouse model.
    Jazani NH; Worobec E; Shahabi S; Nejad GB
    Can J Microbiol; 2005 Apr; 51(4):319-24. PubMed ID: 15980894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide.
    Gudlavalleti SK; Lee CH; Norris SE; Paul-Satyaseela M; Vann WF; Frasch CE
    Vaccine; 2007 Nov; 25(46):7972-80. PubMed ID: 17936445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polysaccharide-iron-regulated cell surface protein conjugate vaccine: its role in protection against Klebsiella pneumoniae-induced lobar pneumonia.
    Chhibber S; Bajaj J
    Vaccine; 1995 Feb; 13(2):179-84. PubMed ID: 7625113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections.
    Clements A; Jenney AW; Farn JL; Brown LE; Deliyannis G; Hartland EL; Pearse MJ; Maloney MB; Wesselingh SL; Wijburg OL; Strugnell RA
    Vaccine; 2008 Oct; 26(44):5649-53. PubMed ID: 18725260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugate vaccines against group B Streptococcus types IV and VII.
    Paoletti LC; Kasper DL
    J Infect Dis; 2002 Jul; 186(1):123-6. PubMed ID: 12089673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response to type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine in healthy adults.
    Baker CJ; Rench MA; Paoletti LC; Edwards MS
    Vaccine; 2007 Jan; 25(1):55-63. PubMed ID: 16919857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates.
    Jennings HJ; Lugowski C
    J Immunol; 1981 Sep; 127(3):1011-8. PubMed ID: 6790606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteins and their derived peptides as carriers in a conjugate vaccine for Streptococcus pneumoniae: self-heat shock protein 60 and tetanus toxoid.
    Amir-Kroll H; Nussbaum G; Cohen IR
    J Immunol; 2003 Jun; 170(12):6165-71. PubMed ID: 12794147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Klebsiella pneumoniae type 3 fimbria-mediated immunity to infection in the murine model of respiratory disease.
    Lavender H; Jagnow JJ; Clegg S
    Int J Med Microbiol; 2005 Jun; 295(3):153-9. PubMed ID: 16047414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
    Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
    Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
    Pichichero ME; Bernstein H; Blatter MM; Schuerman L; Cheuvart B; Holmes SJ;
    J Pediatr; 2007 Jul; 151(1):43-9, 49.e1-2. PubMed ID: 17586189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IC31, a two-component novel adjuvant mixed with a conjugate vaccine enhances protective immunity against pneumococcal disease in neonatal mice.
    Olafsdottir TA; Lingnau K; Nagy E; Jonsdottir I
    Scand J Immunol; 2009 Mar; 69(3):194-202. PubMed ID: 19281531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New meningococcal C polysaccharide-tetanus toxoid conjugate Physico-chemical and immunological characterization.
    Cuello M; Cabrera O; Martinez I; Del Campo JM; Camaraza MA; Sotolongo F; Pérez O; Sierra G
    Vaccine; 2007 Feb; 25(10):1798-805. PubMed ID: 17240485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal administration of a detoxified endotoxin vaccine protects mice against heterologous Gram-negative bacterial pneumonia.
    Chen WH; Kang TJ; Bhattacharjee AK; Cross AS
    Innate Immun; 2008 Oct; 14(5):269-78. PubMed ID: 18809651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against Klebsiella pneumoniae induced lobar pneumonia in rats with lipopolysaccharide and related antigens.
    Rani M; Gupta RK; Chhibber S
    Can J Microbiol; 1990 Dec; 36(12):885-90. PubMed ID: 2081334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization against fatal experimental Klebsiella pneumoniae pneumonia.
    Cryz SJ; Fürer E; Germanier R
    Infect Immun; 1986 Nov; 54(2):403-7. PubMed ID: 3533779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopolysaccharide O-antigen promotes persistent murine bacteremia.
    Lugo JZ; Price S; Miller JE; Ben-David I; Merrill V; Mancuso P; Weinberg JB; Younger JG
    Shock; 2007 Feb; 27(2):186-91. PubMed ID: 17224794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.